Ioannis Athanasiadis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ioannis Athanasiadis has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Michael Tsatsos
Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece
5 shared publications- Michael Tsatsos
2nd Ophthalmology Department, Aristotle University of Thessaloniki, Papageorgiou Hospital, Ag. Pavlou 76, 56429 Thessaloniki, Greece
4 shared publications Nikolaos Ziakas
Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece
3 shared publications- Parwez Hossain
Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
3 shared publications Anant Sharma
Moorfields Eye Hospital, London, United Kingdom
2 shared publications- Aristeidis Konstantinidis
Department of Ophthalmology, University Hospital of Alexandroupolis, Dragana, 68100 Alexandroupolis, Greece
2 shared publications
Latest Publications
- Open Access
- 6 October 2025
- Published by Charles University in Prague, Karolinum Press in Acta Medica (Hradec Kralove, Czech Republic)
- Vol. 68 (2) , 58-62
Eyelid Radiotherapy-Treated Basal and Squamous Cell Carcinomas: A Case Series
Introduction: This case report aims to showcase the successful application of electron hypofractionated radiotherapy in the treatment of eyelid basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Cases Presentation: Two cases are presented involving a 91-year-old Greek female with nodular BCC and an 88-year-old Greek male with ulcerative SCC. Both cases were treated with electron 10MeV irradiation using an ELEKTA 5-15MV linear accelerator. In the first case, a patient with advanced dementia presented with left-upper-eyelid nodular BCC. Following confirmation through biopsy and imaging, hypofractionated electron-beam radiotherapy was chosen, leading to gradual recession of the lesion and no recurrence at the one-year follow-up. In the second case, an elderly male with comorbidities had right-upper-eyelid ulcerative SCC. After systemic evaluation ruled out metastasis, the patient underwent hypofractionated radiotherapy, resulting in unexpected lesion shrinkage, resolution, and absence of recurrence at the 6-month and one-year follow-ups. Conclusions: Hypofractionated electron-beam radiotherapy emerges as an effective and well-tolerated alternative for eyelid tumors, particularly in cases where surgical excision is challenging or contraindicated.
- 6 October 2025
- Published by Charles University in Prague, Karolinum Press in Acta Medica (Hradec Kralove, Czech Republic)
- Vol. 68 (2) , 58-62
Open AccessEyelid Radiotherapy-Treated Basal and Squamous Cell Carcinomas: A Case Series
Introduction: This case report aims to showcase the successful application of electron hypofractionated radiotherapy in the treatment of eyelid basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Cases Presentation: Two cases are presented involving a 91-year-old Greek female with nodular BCC and an 88-year-old Greek male with ulcerative SCC. Both cases were treated with electron 10MeV irradiation using an ELEKTA 5-15MV linear accelerator. In the first case, a patient with advanced dementia presented with left-upper-eyelid nodular BCC. Following confirmation through biopsy and imaging, hypofractionated electron-beam radiotherapy was chosen, leading to gradual recession of the lesion and no recurrence at the one-year follow-up. In the second case, an elderly male with comorbidities had right-upper-eyelid ulcerative SCC. After systemic evaluation ruled out metastasis, the patient underwent hypofractionated radiotherapy, resulting in unexpected lesion shrinkage, resolution, and absence of recurrence at the 6-month and one-year follow-ups. Conclusions: Hypofractionated electron-beam radiotherapy emerges as an effective and well-tolerated alternative for eyelid tumors, particularly in cases where surgical excision is challenging or contraindicated.
- Open Access
- 1 June 2023
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 53 (3) , 136-141
Contact Lens Use Advice–Risks and Outcomes: Are Patients Drowning in Information but Starved for Knowledge?
Kontakt Lens Kullanım Önerileri–Riskler ve Sonuçlar: Çok Fazla Bilgi Mevcut Ancak Hastalar Yeterince Faydalanamıyor mu?
- 1 June 2023
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 53 (3) , 136-141
Open AccessContact Lens Use Advice–Risks and Outcomes: Are Patients Drowning in Information but Starved for Knowledge?
Kontakt Lens Kullanım Önerileri–Riskler ve Sonuçlar: Çok Fazla Bilgi Mevcut Ancak Hastalar Yeterince Faydalanamıyor mu?
- Open Access
- 1 June 2022
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 52 (3) , 208-211
Descemet Stripping Endothelial Keratoplasty for Congenital Aniridia: An Interesting and Challenging Story
Congenital aniridia is a rare condition affecting a wide range of ocular structures, from the ocular surface to the retina. We present the case of a 59-year-old woman with PAX6- and WTI-negative congenital aniridia who developed aniridia-associated keratopathy and progressive endothelial dysfunction with corneal decompensation after cataract surgery. The patient underwent successful ultrathin Descemet stripping endothelial keratoplasty. Despite the challenges faced with an unstable iridolenticular diaphragm, we were pleasantly surprised to see improvement not only of corneal edema and endothelial function but also of the whole cornea, including anterior corneal anatomy and appearance. In conclusion, endothelial transplantation in a patient with aniridia resulted in improvement of all the corneal structures from the endothelium to the stroma, epithelium, and possibly even the ocular surface.
- 1 June 2022
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 52 (3) , 208-211
Open AccessDescemet Stripping Endothelial Keratoplasty for Congenital Aniridia: An Interesting and Challenging Story
Congenital aniridia is a rare condition affecting a wide range of ocular structures, from the ocular surface to the retina. We present the case of a 59-year-old woman with PAX6- and WTI-negative congenital aniridia who developed aniridia-associated keratopathy and progressive endothelial dysfunction with corneal decompensation after cataract surgery. The patient underwent successful ultrathin Descemet stripping endothelial keratoplasty. Despite the challenges faced with an unstable iridolenticular diaphragm, we were pleasantly surprised to see improvement not only of corneal edema and endothelial function but also of the whole cornea, including anterior corneal anatomy and appearance. In conclusion, endothelial transplantation in a patient with aniridia resulted in improvement of all the corneal structures from the endothelium to the stroma, epithelium, and possibly even the ocular surface.
- 24 March 2022
- Published by Springer Nature in Eye
- Vol. 36 (9) , 1721-1723
Intraocular lens implantation in the absence of capsular support: scleral fixation
- 24 March 2022
- Published by Springer Nature in Eye
- Vol. 36 (9) , 1721-1723
Intraocular lens implantation in the absence of capsular support: scleral fixation
- 24 March 2022
- Published by Springer Nature in Eye
- Vol. 36 (9) , 1718-1720
Intraocular lens implantation in the absence of capsular support: iris fixation
- 24 March 2022
- Published by Springer Nature in Eye
- Vol. 36 (9) , 1718-1720
Intraocular lens implantation in the absence of capsular support: iris fixation
- Open Access
- 21 January 2022
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 17 (1) , 123-129
Herpes Zoster Ophthalmicus: A Devastating Disease Coming Back with Vengeance or Finding Its Nemesis?
Herpes zoster ophthalmicus is a frequent, painful, and debilitating condition caused by the reactivation of the varicella-zoster virus alongside the ophthalmic branch of the trigeminal nerve. Twenty-five percent of adults will develop the disease during their lifetime with the risk increasing to one in two over the age of 50. Herpes zoster ophthalmicus presents with a plethora of ocular manifestations ranging from the characteristic rash in the distribution of the ophthalmic branch of the fifth cranial nerve to more severe keratouveitis, disciform keratitis, and even retinal necrosis. Up to 20% of affected patients develop post-herpetic neuralgia which can persist for years after the acute episode, resulting in potentially devastating consequences for the patient’s social, financial, and professional circumstances, as well as their quality of life and daily activities. Shingles prevention studies indicated that the herpes zoster vaccine markedly reduces the burden of the disease, as well as the incidence of both infection and post-herpetic neuralgia. Here we review the vaccinations available for herpes zoster, the reasons behind their limited adoption so far, as well as the future perspectives and challenges associated with this debilitating disease in the era of herpes zoster vaccination and coronavirus disease pandemic.
- 21 January 2022
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 17 (1) , 123-129
Open AccessHerpes Zoster Ophthalmicus: A Devastating Disease Coming Back with Vengeance or Finding Its Nemesis?
Herpes zoster ophthalmicus is a frequent, painful, and debilitating condition caused by the reactivation of the varicella-zoster virus alongside the ophthalmic branch of the trigeminal nerve. Twenty-five percent of adults will develop the disease during their lifetime with the risk increasing to one in two over the age of 50. Herpes zoster ophthalmicus presents with a plethora of ocular manifestations ranging from the characteristic rash in the distribution of the ophthalmic branch of the fifth cranial nerve to more severe keratouveitis, disciform keratitis, and even retinal necrosis. Up to 20% of affected patients develop post-herpetic neuralgia which can persist for years after the acute episode, resulting in potentially devastating consequences for the patient’s social, financial, and professional circumstances, as well as their quality of life and daily activities. Shingles prevention studies indicated that the herpes zoster vaccine markedly reduces the burden of the disease, as well as the incidence of both infection and post-herpetic neuralgia. Here we review the vaccinations available for herpes zoster, the reasons behind their limited adoption so far, as well as the future perspectives and challenges associated with this debilitating disease in the era of herpes zoster vaccination and coronavirus disease pandemic.
- Open Access
- 20 January 2021
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 16 (1) , 135-136
Crystalline Lens Staining with Intracameral Phenylephrine During Cataract Surgery
This is a Photo Essay and does not have an Please download the PDF or view the article in HTML.
- 20 January 2021
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 16 (1) , 135-136
Open AccessCrystalline Lens Staining with Intracameral Phenylephrine During Cataract Surgery
This is a Photo Essay and does not have an Please download the PDF or view the article in HTML.
- Open Access
- 1 January 2019
- Published by Medknow in Taiwan Journal of Ophthalmology
- Vol. 9 (3) , 206-209
Combined photorefractive keratectomy and cross-linking. Pushing the limits
Correction of refractive error through laser-assisted means has soared in popularity in recent years, allowing it to become an increasingly routine surgical procedure. Technique refinement and adjustments resulted in laser-assisted refractive surgery to be combined with treatments such as collagen cross linking (CXL). This has broadened safety parameters and widened the treatment boundaries. Laser correction combined with CXL has been advocated in the treatment of high refractive errors as a safe option for full refractive correction while increasing corneal biomechanical stability. We present a complicated case where a young female patient with a preoperative best-corrected visual acuity (BCVA) of 20/20 in each eye was fully corrected by excimer laser followed by CXL. Factors potentially leading to inflammation, such as ocular surface disease, in addition to laser treatment and CXL, resulted in persistent epithelial defect followed by corneal melt and subsequent thinning. After the treatment, the patient relies on rigid gas-permeable contact lenses, achieving a BCVA of 20/25 and 20/23 in the right eye and left eye, respectively.
- 1 January 2019
- Published by Medknow in Taiwan Journal of Ophthalmology
- Vol. 9 (3) , 206-209
Open AccessCombined photorefractive keratectomy and cross-linking. Pushing the limits
Correction of refractive error through laser-assisted means has soared in popularity in recent years, allowing it to become an increasingly routine surgical procedure. Technique refinement and adjustments resulted in laser-assisted refractive surgery to be combined with treatments such as collagen cross linking (CXL). This has broadened safety parameters and widened the treatment boundaries. Laser correction combined with CXL has been advocated in the treatment of high refractive errors as a safe option for full refractive correction while increasing corneal biomechanical stability. We present a complicated case where a young female patient with a preoperative best-corrected visual acuity (BCVA) of 20/20 in each eye was fully corrected by excimer laser followed by CXL. Factors potentially leading to inflammation, such as ocular surface disease, in addition to laser treatment and CXL, resulted in persistent epithelial defect followed by corneal melt and subsequent thinning. After the treatment, the patient relies on rigid gas-permeable contact lenses, achieving a BCVA of 20/25 and 20/23 in the right eye and left eye, respectively.
- 21 April 2017
- Published by Springer Nature in Eye
- Vol. 31 (9) , 1333-1336
Endothelial keratoplasty: is Descemet membrane endothelial keratoplasty the Holy Grail of lamellar surgery? No
- 21 April 2017
- Published by Springer Nature in Eye
- Vol. 31 (9) , 1333-1336
Endothelial keratoplasty: is Descemet membrane endothelial keratoplasty the Holy Grail of lamellar surgery? No
- Open Access
- 3 March 2017
- Published by Springer Nature in Eye
- Vol. 31 (6) , 823-826
Phytotherapy and intraoperative floppy iris syndrome: the implications
- 3 March 2017
- Published by Springer Nature in Eye
- Vol. 31 (6) , 823-826
Open AccessPhytotherapy and intraoperative floppy iris syndrome: the implications